dr. richard kim on administering aflibercept in colorectal cancer
Published 11 years ago • 893 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:54
dr. richard kim at asco 2022: abstract no. 3521
-
2:16
dr. kim on treatment for braf-mutant colon cancer
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
1:05
dr. peeters on the utility of aflibercept in advanced colorectal cancer
-
6:26
role of the vegf inhibitor aflibercept in metastatic colorectal cancer
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
5:09
egfr therapy as upfront colorectal cancer treatment
-
6:59
optimizing frontline chemotherapy in metastatic colorectal cancer
-
5:01
sequencing decisions in relapsed/refractory colorectal cancer
-
1:18
dr. kim on the evolving treatment landscape of advanced hcc
-
4:44
braf testing in colorectal cancer
-
5:25
second-line and salvage treatment of metastatic colorectal cancer
-
41:36
chemoprevention of colon and rectal cancer and the role of the aryl hydrocarbon receptor
-
1:47
richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
-
1:18
how do i know if i am at risk for colorectal cancer? | dr. cali
-
3:02
final thoughts on the treatment of metastatic colorectal cancer
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
2:02
stage 4 colorectal cancer thriver is running for research